In the present study, long-term administration of BAIBA reduced fasting blood glucose and improved glucose tolerance and insulin sensitivity in mice with STZ/HFD-induced type 2 diabetes, which supports previous findings15. The gene discussed is INS; the disease is type 2 diabetes mellitus.